ONYX PHARMACEUTICALS has a total of 21 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are T2CURE GMBH, GLADIATOR BIOSCIENCES INC and VIROTARG PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Canada | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines | |
#5 | Environmental technology | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Unspecified technologies | |
#7 | Climate change adaptation technologies | |
#8 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Stephens Len | 8 |
#2 | Mccormick Francis | 4 |
#3 | Hermiston Terry | 4 |
#4 | Hawkins Phillip Thomas | 4 |
#5 | Hawkins Lynda K | 3 |
#6 | Johnson Leisa | 3 |
#7 | Braselmann Sylvia | 3 |
#8 | Wu Lelia | 3 |
#9 | Hawkins Phillip T | 2 |
#10 | Bischoff James R | 2 |
Publication | Filing date | Title |
---|---|---|
EP1320582A2 | Adenovirus e1b-55k single amino acid mutants and methods of use | |
EP1017826A2 | Compositions and methods for identifying pkb kinase inhibitors | |
US6187799B1 | Inhibition of raf kinase activity using aryl ureas | |
US5874273A | G-beta-gamma regulated phosphatidylinositol-3' kinase | |
AU1211895A | P53-binding polypeptides and polynucleotides encoding same |